Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropeginterferon for TFR in CML
NCT07105319Phase 4Completed
- Start
- Nov 2021
- Primary completion
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ropeginterferon alfa-2b in chronic myeloid leukemia (CML). Started Nov 2021; status: completed.
02
Drugs
ropeginterferon alfa-2b
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT07105319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07105319.